Edward Kolb

Amministratore Delegato presso The Leukemia & Lymphoma Society, Inc.

Consumer Services

Commercial Services

Profilo

Edward Anders Kolb is currently the President & Chief Executive Officer at The Leukemia & Lymphoma Society, Inc. He holds a doctorate degree from Thomas Jefferson University and an undergraduate degree from the University of Pennsylvania.

Posizioni attive di Edward Kolb

Società	Posizione	Inizio
The Leukemia & Lymphoma Society, Inc. The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY.	Amministratore Delegato	01/05/2023

Tutte le posizioni attive di Edward Kolb

Formazione di Edward Kolb

Thomas Jefferson University	Doctorate Degree
University of Pennsylvania	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Edward Kolb

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
The Leukemia & Lymphoma Society, Inc. The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY.	Commercial Services